Cost-benefit analysis involving addictive goods: contingent valuation to estimate willingness-to-pay for smoking cessation

2009 ◽  
Vol 18 (2) ◽  
pp. 181-202 ◽  
Author(s):  
David L. Weimer ◽  
Aidan R. Vining ◽  
Randall K. Thomas
Keyword(s):  
Smoking Cessation ◽  
Willingness To Pay ◽  
Contingent Valuation ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis

scholarly journals A Cost-Benefit Analysis Using Contingent Valuation Techniques: A Feasibility Study in Spinal Surgery

2008 ◽  
Vol 11 (4) ◽  
pp. 575-588 ◽  
Author(s):  
Mathias Haefeli ◽  
Achim Elfering ◽  
Emma McIntosh ◽  
Alastair Gray ◽  
Atul Sukthankar ◽  
...  
Keyword(s):  
Contingent Valuation ◽  
Feasibility Study ◽  
Spinal Surgery ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis

scholarly journals Potential Costs and Benefits of Statewide Smoking Cessation in Pennsylvania

2011 ◽  
Vol 6 (1) ◽  
pp. 25-32
Author(s):  
Jill S. Rumberger ◽  
Christopher S. Hollenbeak
Keyword(s):  
Smoking Cessation ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Retail Price ◽  
Smoking Cessation Program ◽  
Benefit Analysis ◽  
Costs And Benefits ◽  
Productivity Losses ◽  
The Cost ◽  
Treatment Alternatives

AbstractObjectives:To determine whether the cost of a statewide smoking cessation program in Pennsylvania could be justified by the benefits.Methods:A cost-benefit analysis of statewide access to smoking cessation programs. We compared three treatment alternatives, both with and without counselling: nicotine replacement therapy, bupropion and varenicline.Results:While the retail price of a pack of cigarettes in Pennsylvania is on average US$4.72, the combined medical costs and productivity losses in Pennsylvania attributable to each pack of cigarettes sold are approximately US$23.78 per pack of cigarettes. The ratio of benefits to cost varied from US$0.97 to US$2.76 saved per dollar spent on smoking cessation programs, depending upon the type of intervention.Conclusions:For most smoking cessation treatments, the benefits of a statewide smoking cessation program in Pennsylvania would greatly outweigh its costs.

The Concept of Cost in the Economic Evaluation of Health Care: A Theoretical Inquiry

1994 ◽  
Vol 10 (4) ◽  
pp. 675-682 ◽  
Author(s):  
Magnus Johannesson
Keyword(s):  
Health Care ◽  
Economic Evaluation ◽  
Willingness To Pay ◽  
Treatment Program ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Economic Evaluations ◽  
Benefit Analysis ◽  
Full Economic Evaluation ◽  
The Individual

AbstractThe costs included in economic evaluations of health care vary from study to study. Based on the theory of cost-benefit analysis, the costs that should be included in an economic evaluation are those not already included in the measurement of willingness to pay (net willingness to pay above any treatment costs paid by the individual) in a cost-benefit analysis or in the easurement of effectiveness in a cost-effectiveness analysis. These costs can be defined as the onsumption externality of the treatment (the change in production minus consumption for those included in the treatment program). For a full economic evaluation, the consequences for those included in the treatment program and a caring externality (altruism) should also be added.

A Cost–Benefit Analysis of the Outpatient Smoking Cessation Services in Taiwan From a Societal Viewpoint

2011 ◽  
Vol 14 (5) ◽  
pp. 522-530 ◽  
Author(s):  
Pei-Ching Chen ◽  
Yue-Chune Lee ◽  
Shih-Tzu Tsai ◽  
Chih-Kuan Lai
Keyword(s):  
Smoking Cessation ◽  
Cost Benefit Analysis ◽  
Cost Benefit ◽  
Benefit Analysis ◽  
Smoking Cessation Services

scholarly journals Mortality-risk valuation, age and cause of death: out-of-hospital cardiac arrest

2017 ◽  
Vol 5 (2) ◽  
pp. 28-40
Author(s):  
Björn Sund
Keyword(s):  
Cardiac Arrest ◽  
Willingness To Pay ◽  
Cause Of Death ◽  
Road Traffic ◽  
Cost Benefit Analysis ◽  
Stated Preference ◽  
Cost Benefit ◽  
Transport Sector ◽  
Benefit Analysis ◽  
Hospital Cardiac Arrest

Economic evaluation of policies regarding out-of-hospital cardiac arrest (OHCA) is important. The value of a statistical life (VSL) for OHCA victims is the most important component in a cost-benefit analysis of interventions that have the possibility to reduce mortality from this cause. This value is not known. We use responses to a national Swedish mail survey, based on the stated-preference technique to directly elicit individuals’ hypothetical willingness to pay for a reduced risk of dying from OHCA. A lower-bound estimate of VSL for OHCA would be in range of SEK 30 to 50 million. The value is found to be higher than for comparable VSL estimates from the transport sector, even though individuals who suffer OHCAs are generally older and less healthy than people who die in road traffic accidents. The results indicate that it is not an overestimation to use the ‘baseline’ VSL value from the transport sector (SEK 24 million) in cost-benefit analysis of OHCA policy decisions and that the cause of death is important when examining willingness to pay for death risk reductions. We do not support a general declining VSL due to the age of the victims, i.e. a ‘senior death discount’, for this cause of death.Published: Online January 2017. In print December 2017.

Sign in / Sign up

Export Citation Format

Share Document